Condies de armazenamento Conservar num local fresco e seco
For NHS access, NICE then has to recommend it through a technology appraisal
Loghin, C
Laboratory evaluation typically includes complete blood count to assess for anemia and determine acuity of blood loss, comprehensive metabolic panel to evaluate renal function and electrolytes (particularly relevant given tirzepatide's gastrointestinal effects), and coagulation studies if bleeding disorder is suspected
Any family history of thyroid cancer or medullary thyroid carcinoma raises additional scrutiny since semaglutide carries a black-box warning related to animal thyroid studies

Before starting Ozempic , you should discuss your complete medical history with your healthcare provider, particularly if you have: Hashimoto's thyroiditis or any thyroid condition Thyroid nodules or concerning neck symptoms Previous thyroid surgery or radioactive iodine treatment Difficulty achieving stable thyroid function despite levothyroxine treatment Pre-existing diabetic retinopathy Plans for pregnancy (semaglutide should be stopped at least 2 months before planned conception) During Ozempic treatment , contact your GP if you experience: Symptoms suggesting thyroid dysfunction : palpitations, significant anxiety, tremor, excessive sweating, or worsening fatigue, constipation, and cold intolerance Neck symptoms : a lump in the neck, difficulty swallowing, persistent hoarseness, or neck pain (which may require urgent cancer referral per NICE NG12) Severe gastrointestinal effects : persistent vomiting preventing adequate nutrition or medication absorption, severe abdominal pain, or signs of pancreatitis Hypoglycaemia symptoms : particularly if taking Ozempic alongside insulin or sulphonylureas Significant, rapid weight loss : requiring potential adjustment of levothyroxine dose Visual changes or deterioration : which could indicate diabetic retinopathy complications Routine monitoring should include thyroid function tests 68 weeks after significant weight changes or levothyroxine dose adjustments, then annually when stable (per NICE NG145)
